Elevation Oncology, Inc. (ELEV)
NASDAQ: ELEV · IEX Real-Time Price · USD
2.600
-0.040 (-1.52%)
Jul 22, 2024, 10:13 AM EDT - Market open
Elevation Oncology Employees
Elevation Oncology had 29 employees as of December 31, 2023. The number of employees decreased by 4 or -12.12% compared to the previous year.
Employees
29
Change (1Y)
-4
Growth (1Y)
-12.12%
Revenue / Employee
n/a
Profits / Employee
-$1,356,966
Market Cap
143.15M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 29 | -4 | -12.12% |
Dec 31, 2022 | 33 | 10 | 43.48% |
Dec 31, 2021 | 23 | 15 | 187.50% |
Dec 31, 2020 | 8 | - | - |
Related Stocks
Company Name | Employees |
---|---|
InfuSystem Holdings | 516 |
Cellectis | 221 |
Quantum-Si incorporated | 159 |
ProQR Therapeutics | 157 |
Zomedica | 144 |
Alpha Tau Medical | 121 |
PDS Biotechnology | 25 |
Citius Pharmaceuticals | 22 |
ELEV News
- 25 days ago - Elevation Oncology Announces Planned Combination Strategy for EO-3021 in Patients with Gastric or Gastroesophageal Junction Cancer - PRNewsWire
- 2 months ago - Elevation Oncology to Present at the Citizens JMP Life Sciences Conference - PRNewsWire
- 2 months ago - Elevation Oncology Reports First Quarter 2024 Financial Results and Highlights Recent Business Achievements - PRNewsWire
- 3 months ago - Elevation Oncology Presents Preclinical Proof-of-Concept Data for HER3-ADC Program at AACR Annual Meeting 2024 - PRNewsWire
- 4 months ago - Elevation Oncology Reports Fourth Quarter and Full Year 2023 Financial Results and Highlights Recent Business Achievements - PRNewsWire
- 4 months ago - Elevation Oncology to Present Preclinical Proof-of-Concept Data for HER3-ADC Program at the American Association for Cancer Research (AACR) Annual Meeting 2024 - PRNewsWire
- 5 months ago - Elevation Oncology Appoints Experienced Clinical Development Leaders Julie Cherrington, Ph.D. and Alan Sandler, M.D. - PRNewsWire
- 5 months ago - SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation of Elevation Oncology (ELEV) and Encourages Investors to Contact the Firm - PRNewsWire